Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Open accessThe DOI matches its Crossref record; 234 of the 236 references it cites were found in a registry or an index; 50 of the 187 sources its claims cite were checked for support.
Abstract
Organisms are continually exposed to exogenous and endogenous sources of reactive oxygen species (ROS) and other oxidants that have both beneficial and deleterious effects on the cell. ROS have important roles in a wide range of physiological processes; however, high ROS levels are associated with oxidative stress and disease progression. Oxidative stress has been implicated in nearly all major human diseases, from neurogenerative diseases and neuropsychiatric disorders to cardiovascular disease, diabetes, and cancer. Antioxidant defence systems have evolved as a means of protection against oxidative stress, with the transcription factor Nrf2 as the key regulator. Nrf2 is responsible for regulating an extensive panel of antioxidant enzymes involved in the detoxification and elimination of oxidative stress and has been extensively studied in the disease contexts. This review aims to provide the reader with a general overview of oxidative stress and Nrf2, including basic mechanisms of Nrf2 activation and regulation, and implications in various major human diseases.
Overview
CoChat Summary
TL;DR
This narrative review summarizes oxidative stress and the Keap1-Nrf2 antioxidant pathway, covering Nrf2 activation, regulation, and interacting proteins. It highlights Nrf2 as the master regulator of antioxidant and phase II enzymes, with protective roles in many diseases but also a harmful “dark side” in cancer.
Key findings
- Nrf2 is the key transcriptional regulator of ARE-driven antioxidant and phase II enzyme genes; under basal conditions Nrf2 has a short half-life of only 10–30 min, and Keap1 mediates its Cul3-dependent ubiquitination and proteasomal degradation.
- Keap1 senses oxidative stress through reactive cysteines: human Keap1 contains 27 cysteine residues, about 4% of its amino acid content versus a 2% average for the human proteome; Cys273 and Cys288 are required for sensing oxidative stress under basal and stress conditions, while Cys151 may be required only during oxidative stress.
- The Keap1-Nrf2 two-site recognition model depends on the high-affinity ETGE motif and low-affinity DLG motif; the ETGE motif has a binding affinity two orders of magnitude higher than the DLG motif, making DLG an “on/off switch” for Nrf2 ubiquitination.
- Nrf2 is implicated in major human diseases: reduced nuclear Nrf2 is observed in Alzheimer’s disease brain regions; Nrf2 pathway alterations occur in 34% of squamous cell lung cancer specimens; and Nrf2 hyperactivation can promote chemoresistance to drugs such as cisplatin, 5-fluorouracil, docetaxel, and bortezomib.
Methods
- Design: narrative review providing a general overview of oxidative stress, Nrf2 mechanisms, and implications in human disease.
- Data or sample: no primary experimental data or human/animal sample; the paper synthesizes published literature and cites prior studies, reviews, and model-organism findings.
- Main analysis: descriptive synthesis of ROS/RNS biology, antioxidant enzymes, ARE regulation, canonical and non-canonical Keap1-Nrf2 regulation, Nrf2-interacting proteins, and disease associations including neurodegenerative disease, neuropsychiatric disorders, cardiovascular disease, diabetes, cancer, inflammation, and aging.
Limitations
- The paper does not state formal limitations; it describes the review as a “general overview” and notes that several topics are “briefly discussed” or “beyond the scope of this review.”
- Evident from the text: as a narrative review, it lacks a systematic search strategy, predefined inclusion criteria, or quantitative synthesis, and it presents no primary data.
- Evident from the text: disease sections are broad and selective rather than exhaustive, and the authors repeatedly refer readers to other reviews for more detailed discussion.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
23 Valid · 5 Not valid · 72 Not checked · 17 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“WTX is also involved in oxidative stress regulation through its competitive binding to the Keap1, which inhibits Nrf2 ubiquitination [84].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.7. Keap1-Interacting Proteins
What the sources say
- Disputedcites [84] Copple I.M. Lister A. Obeng A.D. Kitteringham N.R. Jenkins R.E. Layfield R. Foster B.J. Goldring C.E. Park B.K. Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway J. Biol. Chem. 2010 285 16782 16788 10.1074/jbc.M109.096545 20378532 PMC2878012 sourceExperimental — accuracy not yet measured
The Discussion attributes competitive binding to Keap1 and reduced Nrf2 ubiquitination to SQSTM1 (p62), not WTX. The paper’s stated mechanism therefore identifies a different protein from the one in the citing sentence; no page number is available in our copy. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Chronic oxidative stress and the resultant oxidative damage have been implicated in many human diseases including cardiovascular disease, neurodegenerative diseases, diabetes, cancer, and the aging process [18,19,20,21,22].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 1. Oxidative Stress > 1.2. Oxidative Stress
What the sources say
- Partly supportedcites [18] Reuter S. Gupta S.C. Chaturvedi M.M. Aggarwal B.B. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic. Biol. Med. 2010 49 1603 1616 10.1016/j.freeradbiomed.2010.09.006 20840865 PMC2990475 sourceExperimental — accuracy not yet measured
The Introduction links sustained oxidative stress and cellular damage to cancer, and describes increased oxidative stress and accumulated molecular damage in aging. The passages from the body of our copy do not substantiate the additional claims about cardiovascular disease, neurodegenerative diseases, or diabetes; those conditions appear in the retrieved reference titles. (LLM, conf=0.84)
- Partly supportedcites [19] Alfadda A.A. Sallam R.M. Reactive Oxygen Species in Health and Disease J. Biomed. Biotechnol. 2012 2012 936486 10.1155/2012/936486 22927725 PMC3424049 sourceExperimental — accuracy not yet measured
The Introduction (section 1; page unavailable) links ROS to cancer, diabetes, cardiovascular disease, and aging, and section 5.3 links oxidative stress to diabetic complications. The passages found do not establish the claimed link to neurodegenerative diseases or characterize the whole disease list specifically as consequences of chronic oxidative stress and resultant damage. (LLM, conf=0.84)
- Partly supportedcites [20] Asmat U. Abad K. Ismail K. Diabetes mellitus and oxidative stress—A concise review Saudi Pharm. J. 2016 24 547 553 10.1016/j.jsps.2015.03.013 27752226 PMC5059829 sourceExperimental — accuracy not yet measured
The 'Oxidative stress and antioxidants' section links oxidative damage to a wide variety of diseases, notably cancer and heart disease. 'Oxidative stress and diabetic complications' also links oxidative stress to diabetes and coronary artery disease. Our copy does not establish the claimed link to neurodegenerative diseases or aging; it mentions aging as a possible factor contributing to oxidative stress, not as a resulting condition. No page numbers are available in our copy. (LLM, conf=0.86)
- Supportedcites [21] Liguori I. Russo G. Curcio F. Bulli G. Aran L. Della-Morte D. Gargiulo G. Testa G. Cacciatore F. Bonaduce D. Oxidative stress, aging, and diseases Clin. Interv. Aging 2018 13 757 772 10.2147/CIA.S158513 29731617 PMC5927356 source
The sections on cardiovascular disease, diabetes, cognitive impairment and dementia, and cancer each link oxidative stress or oxidative damage to the named conditions. The section on the theory of aging describes accumulated oxidative damage as a proposed explanation for age-related functional loss. Page numbers are not available in our copy. (LLM, conf=0.92)
- Not checked yetcites [22] Barnham K.J. Masters C.L. Bush A.I. Neurodegenerative diseases and oxidative stress Nat. Rev. Drug Discov. 2004 3 205 214 10.1038/nrd1330 15031734 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Nrf2 regulates the expression of a multitude of antioxidant and phase II enzyme genes and is negatively regulated by Kelch-like ECH-associated protein (Keap1) [49], a substrate adaptor protein that binds to Nrf2 in the cytosol to facilitate its polyubiquitination by the Cullin 3 (Cul3) E3 ubiquitin ligase for proteasomal degradation [50,51,52].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.1. Keap1-Nrf2 Signalling
What the sources say
- Supportedcites [49] Itoh K. Wakabayashi N. Katoh Y. Ishii T. Igarashi K. Engel J.D. Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain Genes Dev. 1999 13 76 86 10.1101/gad.13.1.76 9887101 PMC316370 source
The Abstract states that Keap1 suppresses Nrf2 transcriptional activity by binding its amino-terminal regulatory domain. The Discussion also describes Nrf2 as sequestered in the cytoplasm through its association with Keap1. This source is cited for negative regulation by Keap1; the later Cul3, polyubiquitination, and degradation mechanism is attached to citations [50–52], not this one. (LLM, conf=0.94)
- Supportedcites [50] Nguyen T. Sherratt P.J. Huang H.C. Yang C.S. Pickett C.B. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome J. Biol. Chem. 2003 278 4536 4541 10.1074/jbc.M207293200 12446695 source
Citation [49] is attached to the claim that Keap1 negatively regulates Nrf2. The paper describes Keap1 retaining Nrf2 in the cytoplasm and says that their dissociation allows Nrf2 to enter the nucleus (introductory passage and Discussion). The subsequent Cul3 polyubiquitination mechanism is attached to citations [50–52], not this source. (LLM, conf=0.92)
- Supportedcites [51] Kobayashi A. Kang M.I. Okawa H. Ohtsuji M. Zenke Y. Chiba T. Igarashi K. Yamamoto M. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2 Mol. Cell. Biol. 2004 24 7130 7139 10.1128/MCB.24.16.7130-7139.2004 15282312 PMC479737 source
The Abstract states that Keap1 retains Nrf2 in the cytoplasm, binds it directly, and acts as an adaptor for Cul3-based E3 ligase in its proteasomal degradation. The Results report ubiquitin-chain conjugation and show that Nrf2 ubiquitination depends on its interaction with Keap1. (LLM, conf=0.93)
- Not checked yetcites [52] McMahon M. Itoh K. Yamamoto M. Hayes J.D. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression J. Biol. Chem. 2003 278 21592 21600 10.1074/jbc.M300931200 12682069 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Oxidative damage has been implicated in all major neurodegenerative diseases including Alzheimer’s disease (AD) [108,109], Parkinson’s disease (PD) [110,111], Huntington’s disease (HD) [112,113], amyotrophic lateral sclerosis (ALS) [114], and multiple sclerosis (MS) [115].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 3. Nrf2 in Human Disease > 3.1. Neurodegenerative Disease
What the sources say
- Supportedcites [108] Smith M.A. Rottkamp C.A. Nunomura A. Raina A.K. Perry G. Oxidative stress in Alzheimer’s disease Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 2000 1502 139 144 10.1016/S0925-4439(00)00040-5 10899439 source
This source is cited for the Alzheimer’s disease portion of the sentence, not for the other listed diseases. Section 2, “Oxidative damage,” describes oxidative damage in AD, and the Conclusion states that oxidative stress plays an important role in AD pathogenesis. (LLM, conf=0.94)
- Supportedcites [109] Cioffi F. Adam R.H.I. Broersen K. Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease J. Alzheimer’s Dis. JAD 2019 72 981 1017 10.3233/JAD-190863 31744008 PMC6971833 source
The sentence assigns separate citations to each disease; this source supports the Alzheimer’s disease portion. The Introduction reports early hallmarks of oxidative stress in AD, and “Oxidative Damage to Biomacromolecules in Alzheimer’s Disease” describes oxidative damage in AD brain tissue. The source need not support the other diseases, which have their own citations. (LLM, conf=0.92)
- Not checked yetcites [110] Dias V. Junn E. Mouradian M.M. The Role of Oxidative Stress in Parkinson’s Disease J. Park. Dis. 2013 3 461 491 10.3233/JPD-130230 PMC4135313 24252804
- Supportedcites [111] Blesa J. Trigo-Damas I. Quiroga-Varela A. Jackson-Lewis V.R. Oxidative stress and Parkinson’s disease Front. Neuroanat. 2015 9 91 10.3389/fnana.2015.00091 26217195 PMC4495335 source
The citation is attached to the Parkinson’s disease portion of the sentence, not the list of other diseases. The Introduction states that Parkinson’s disease is related to excess reactive oxygen species and that oxidative stress is thought to underlie cellular dysfunction and death in PD. (LLM, conf=0.94)
- Not checked yetcites [112] Browne S.E. Ferrante R.J. Beal M.F. Oxidative stress in Huntington’s disease Brain Pathol. 1999 9 147 163 10.1111/j.1750-3639.1999.tb00216.x 9989457 PMC8098260 source
- Supportedcites [113] Kumar A. Ratan R.R. Oxidative Stress and Huntington’s Disease: The Good, the Bad, and the Ugly J. Huntingt. Dis. 2016 5 217 237 10.3233/JHD-160205 27662334 PMC5310831 source
The citation to this source is attached to Huntington’s disease, not to the other diseases in the sentence. The section “Is Oxidative Stress a Cause or a Consequence in HD Pathology?” reports increased oxidative damage in postmortem HD brains and describes oxidative stress as implicated in HD pathogenesis. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Nrf2 association requires the homodimerization of Keap1 [74].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.4. Keap1-Dependent Nrf2 Regulation
What the sources say
- Supportedcites [74] Zipper L.M. Mulcahy R.T. The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm J. Biol. Chem. 2002 277 36544 36552 10.1074/jbc.M206530200 12145307 source
The Discussion states that the integrity of the Keap1–Nrf2 complex depends on Keap1 dimerization and calls the BTB/POZ dimerization function a prerequisite for Nrf2 binding. The Results (Fig. 3B) also report reduced Nrf2 association with a Keap1 mutant deficient in homodimerization. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
67 more claims · 13 with their cited sources checked
Create a free account to see all 117 claims and to verify the 137 references still open.
- It may state two separate claims as one. 42
- Probably not a substantial claim. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The transcription factor Nrf2 acts as a central regulator of the host’s primary antioxidant defense system [73,74] and determines cellular fate during envenomation.”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 1. Oxidative Stress > 1.1. Reactive Oxygen Species
“superoxide radicals which are readily detoxified to hydrogen peroxide (H2O2) by antioxidant enzymes such as catalase and glutathione peroxidase.”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 1. Oxidative Stress > 1.3. Antioxidant Response Enzymes
“SODs are responsible for the dismutation (simultaneous oxidation and reduction) and breakdown of superoxide radicals into molecular oxygen and hydrogen peroxide”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.7. Keap1-Interacting Proteins
“In 2010, five independent groups discovered the interaction between p62 and Keap1 [77,78,79,80,81].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > References
“78. Baird L. Yamamoto M. The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway Mol. Cell. Biol. 2020 40 e00099-20”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > 2. Keap1-Nrf2 Antioxidant Pathway > 2.7. Keap1-Interacting Proteins
“WTX is also involved in oxidative stress regulation through its competitive binding to the Keap1, which inhibits Nrf2 ubiquitination [84].”
§ Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease > References
“84. Copple I.M. Lister A. Obeng A.D. Kitteringham N.R. Jenkins R.E. Layfield R. Foster B.J. Goldring C.E. Park B.K. Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway”
Citations
Cites
1 retracted
Zhou, S., Ye, W., Duan, X., Zhang, M., & Wang, J. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2537-1 · Cited by 18
RetractedRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Reactive oxygen species: Metabolism, oxidative stress, and signal transduction
Apel, K., & Hirt, H. (2004) · Annual Review of Plant Biology · doi:10.1146/annurev.arplant.55.031903.141701 · Cited by 11,723 · cited 3×
“Extensive or prolonged exposure to ROS results in oxidative stress, a deleterious process that damages lipi s, proteins, and nucleic acids in the cell, thereby inhibiting their normal function [2].”
BackgroundInfluentialPolazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Free Radicals in Biology and Medicine
Halliwell, B., & Gutteridge, J. M. C. (2015) · doi:10.1093/acprof:oso/9780198717478.001.0001 · Cited by 8,990
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Free radicals, metals and antioxidants in oxidative stress-induced cancer
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680 · cited 1×
“RNS and ROS often act together to cause cellular damage [8].”
BackgroundOxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
Role of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903
Cited by
Items 801–900 of 1,000
Egambaram, S., Ghouse, M. R., Balasundar, A. K., & Parsanathan, R. (2025) · Oral Oncology Reports · doi:10.1016/j.oor.2025.100726
Wang, Y., Pang, D., & Li, N. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.07.641679
“Importantly, Erdr1 is highly interconnected with the Nrf2 signaling pathway 75,78 , a master regulator of the antioxidant response 79 .”
Hatipoğlu, Ö. F., Nishinaka, T., Yaykaşlı, K. O., Mori, S., Watanabe, M., Toyomura, T., Nishibori, M., Hirohata, S., Wake, H., & Takahashi, H. K. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1561628
Pre-clinical evidence for mitochondria as a therapeutic target for luteolin: A mechanistic view
de Oliveira, M. R. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111492 · Cited by 1
Romantseva, T. O., & Kostenko, V. О. (2025) · Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії · doi:10.31718/2077-1096.25.1.134
“[26].”
Ryabova, Y. V., Karimov, D. O., Repina, E. F., Якупова, Т. Г., Khusnutdinova, N. Y., & Smolyankin, D. A. (2025) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20250212
Shilpa, T., Vaishnavi, A., & Nair, R. A. (2025) · Pharmacological Research - Reports · doi:10.1016/j.prerep.2025.100041
Tjia, J., Rombelayuk, E. A., & Romadhan, M. I. (2025) · Sumatera Medical Journal · doi:10.32734/sumej.v8i2.18218
“[47, 48].”
Molecular insights into oxidative stress and inflammatory responses in metabolic disorders
Akash, M. S. H., & Rehman, K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36312-2.00013-9
Vidal-Correoso, D., Caballero-Herrero, M. J., Muñoz-Morales, A. M., Mateo, S. V., Jover-Aguilar, M., Alconchel, F., Martínez-Alarcón, L., López, V., Ríos, A., Cascales-Campos, P. A., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5345886
Berköz, M. (2025) · Cell and Tissue Biology · doi:10.1134/s1990519x25600267
“Nrf2 plays a key role in the biological defence mechanism against oxidative stress by binding to antioxidant response elements present in antioxidant protein genes such as HO-1 and increasing the expression these proteins (Ngo and Duennwald, 2022).”
Cellular signaling cascade regulating embryonic development under oxidative stress
Duttaroy, A. K., & Jena, A. B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-43884-4.00021-0
Stem cell homeostasis and differentiation under oxidative stress
Duttaroy, A. K., & Jena, A. B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-43884-4.00009-x
Role of Sulforaphane in Neurodegenerative Diseases: A Focus on Parkinson’s Disease
Ali, M. N., Goel, R., & Kumar, R. (2025) · International Journal of Newgen Research in Pharmacy & Healthcare · doi:10.61554/ijnrph.v3i1.2025.163
Relationship between simvastatin pharmacokinetics and muscle toxicity in male mice
Bouitbir, J., Sanvee, G. M., Panajatovic, M. V., Fehrenbach, N. B., Fréchard, T., Manivannan, M., Duthaler, U., & Krähenbühl, S. (2025) · Food and Chemical Toxicology · doi:10.1016/j.fct.2025.115688
Ahr Signaling Pathway Mediated Developmental Toxicity in Zebrafish Embryos Induced by Β-IononePreprint
Liu, S., Huang, Y. Z., Teng, Y., Tao, Q., He, S., Xu, J., Xie, J., Zhu, F., Luo, Y., & Zhou, W. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5390599
Dey, P., Das, A., Barbhuiya, S. N., Banik, A., & Giri, S. (2025) · Traditional & Kampo Medicine · doi:10.1002/tkm2.70016
“The potential mechanism may involve Nrf2 pathway activation, a key regulator of antioxidant defense, leading to the upregulation of endogenous antioxidant enzymes like SOD and GSH [27].”
Zhang, J., Piracha, Z. Z., Saeed, U., Ozsahin, D. U., Waseem, M., & Zhang, Y. (2025) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr-163368
“To counteract ROS-induced damage, cells activate the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, which upregulates antioxidant defense genes, including heme oxygenase-1 (HO-1) and glutamate-cysteine ligase catalytic (GCLC) subunit (13).”
Fayed, H. A., Abdel-Sattar, S. A., & Awad, A. S. (2025) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgaf064
Çetinkaya, S., Haydaroğlu, Ü. S., Gök, H. N., Nartop, P., Bağdat, R. B., Özbek, F., Ayaz, K., & Uranbey, S. (2025) · Plant Cell Tissue and Organ Culture (PCTOC) · doi:10.1007/s11240-025-03171-7
“Superoxide dismutase (SOD), cata - lase (CAT), and glutathione peroxidase (GPx) are the main enzymes that maintain the redox balance of cells (Tretter et al. 2021; Ngo and Duennwald 2022).”
Pan, Y., Hsieh, Y., Wu, T.-K., & Chen, H.-P. (2025) · 童綜合醫學雜誌 · doi:10.4103/etmj.etmj-d-25-00005 · Cited by 1
Mavillapalli, R. C., Janani, D. M., Ravi, Y., & Rajasekaran, N. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.01.672999
Adeyi, O. E., Somade, O. T., Ugwor, E. I., Ajayi, O. S., Adeyi, A. O., Adams, S. O., Ayanwale, M. O., Adediran, O. O., Ambali, G., Phillip, Y. P., et al. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100360
Padovam, J. C., Ferreira, R. L. U., Torres-Rêgo, M., Daniele-Silva, A., Sales, M. C., de Lima, K. C., Barbosa, F., Sena‐Evangelista, K. C. M., & Pedrosa, L. F. C. (2025) · BioMetals · doi:10.1007/s10534-025-00720-7
Vidal-Correoso, D., Caballero-Herrero, M. J., Muñoz-Morales, A. M., Mateo, S. V., Jover-Aguilar, M., Alconchel, F., Martínez-Alarcón, L., López‐López, V., Ríos, A., Cascales-Campos, P. A., et al. (2025) · Antioxidants · doi:10.3390/antiox14091104
“NADPH oxidase activity increases ROS production and induces Nuclear factor erythroid 2-related factor (NRF2) activation, along with the expression of its target genes, such as HMOX1 and NQO1 [36].”
Aljabali, A. A. A., Alkaraki, A. K., & Obeid, M. A. (2025) · Current Neuropharmacology · doi:10.2174/011570159x371971250818110608
“It can work with Nrf2 mecha-910 nisms to reduce oxidative stress and protect neurons [61, 62].”
Tsushida, K., Yamasaki, K., Haruyama, W., & Kitayama, T. (2025) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b25-00273
Protective Role of Vitamin D in Attenuating RAI-Induced Liver Injury in Rats
Atli, M., Akbulut, A., Kuru, S., Koca, N. T., Demirel, K., Koca, G., Şeneş, M., Yumuşak, N., & Korkmaz, M. (2025) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-025-00348-6 · Cited by 1
Lee, E., & Hong, J. H. (2025) · Antioxidants · doi:10.3390/antiox14101191 · Cited by 1
Beyond petri dish: small animal models bridge in vitro and in vivo antioxidant assays
Samarasinghe, H. G. A. S., & Santhiravel, S. (2025) · Journal of Food Bioactives · doi:10.26599/jfb.2025.95031420
Fucoxanthin as a marine-derived anti-inflammatory agent: Molecular targets and therapeutic insights
Manochkumar, J., Efferth, T., & Ramamoorthy, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24017-1.00012-9
Mahanta, D. K., Parida, C., & Chowdhuri, S. (2025) · ChemistrySelect · doi:10.1002/slct.202501456
OuYang, J., Xu, Q., Wen, J., Liu, H., Yang, Y. R., & Hu, J. (2026) · Aquaculture Reports · doi:10.1016/j.aqrep.2026.103669
Role of Antioxidants and Oxidants in Saliva
Punj, A., Chaturvedi, M., Reddy, A. P. K., Vasudevan, S., Bommala, M., Atchuta, A., Singh, A., Priya, C., Mishra, A., Paul, S., et al. (2025) · Dentistry · doi:10.5772/intechopen.1012615
Targeting neural stem cell senescence for brain aging and neurodegeneration
Li, J., & Zhang, X. (2025) · New cell · doi:10.61958/ncrq6446
Wang, S., Li, D., Deng, W., Wu, S., Wei, Y., & Wei, G. (2025) · Journal of Applied Toxicology · doi:10.1002/jat.4963
“When oxidative stress occurs, Nrf2 can separate from Keap1 and translocate to the nucleus, where it regulates antioxidant responses (Ngo and Duennwald 2022).”
Costa, F. C., de Assis, E. I. T., Nascimento, D. R., Neto, M. F. D. L., Silva, A. A., Azevedo, V. A. N., Ribeiro, R. P., Silva, B. R., Donato, M. A. M., Reis, A. V. F., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7760007/v1
Wan, Y., Hong, Y., Ji, X., Xiang, J., Liu, J., Liang, L., Ren, M., Chen, W., Xu, T., Li, Z., et al. (2025) · Advanced Science · doi:10.1002/advs.202417142 · Cited by 1
Jeong, J. H., Yi, J., & Pak, J. H. (2025) · Genes & Genomics · doi:10.1007/s13258-025-01692-1
Wang, R., Tian, X., Liu, P., & Lian, F. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1667486 · Cited by 1
Astaxanthin: A promising nutraceutical for cardiovascular health
Daoud, M. S. (2025) · Journal of King Saud University - Science · doi:10.25259/jksus_512_2025 · Cited by 1
Gelerstein-Claro, S., Espinoza-Jaña, B., Chichiarelli, S., Saso, L., & Rodrigo, R. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001367
Optimization of photobiomodulation therapy for spinal cord injury: A review
Drew, I. K. M., Harvey, A. R., Wallace, V. P., & Hodgetts, S. I. (2025) · Photochemistry and Photobiology · doi:10.1111/php.70041
“106 This enables translocation to the nucleus, where it binds onto the antioxidant response element on corresponding promoters to increase synthesis 106 of heme oxygenase, SOD, and NAD(P)H: quinone oxidoreductase 1 105 (Figure 7).”
Bingül, İ., Koç, B., Hanikoglu, A., Delen, E., Ömer, B., Genç, S., & Zülfikar, B. (2025) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-025-02211-8
Therapeutic potential of extracellular mitochondria: applications and challenges
Mas‐Bargues, C., Huete-Acevedo, J., Arnal-Forné, M., Atencia-Rabadán, S., de Santiago-Montesinos, J., Dorosz, K., & Borrás, C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29283-5.00009-1
Özeken, H. İ., Sağraç, D., Kırbaş, O. K., Taşlı, P. N., & Şahin, F. (2025) · Molecular Immunology · doi:10.1016/j.molimm.2025.11.002
Szlachcikowska, D., Koszła, O., Sołek, P., & Tabęcka-Łonczyńska, A. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05301-w
Abedi, F., Nehzomi, Z. S., Kebria, M. S., Omidi, A., & Shirani, K. (2025) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2025.100167
Alyassery, Y. J. H., Bairam, A. F., & Martin, C. M. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.102170
“While this activation serves as a protective response, sustained or excessive ROS can overwhelm cellular defenses, resulting in damage or cell death [44,45].”
Hsia, C., Yang, C.-M., Chang, C.-C., Yen, T., Darmanto, A. G., Huang, C., & Sheu, J. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13758 · Cited by 2
“…should therefore examine additional Nrf2 targets, including other cytoprotective enzymes beyond HO‑1, such as NQO1, as well as proteins directly involved in cell motility, particularly matrix metalloproteinases (such as MMP‑2 and MMP‑9), which are functionally linked to macrophage migra‑ tion (48).”
Che, J., & Zhu, Y. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70604
“Autophagy dysfunction via p62/Sequestosome 1(SQSTM1) also enhances Nrf2 activation by sequestering Keap1 [18].”
Padmalayam, P. M., Kuttithodi, A. M., Tom, A., Job, J. T., George, S., & Narayanankutty, A. (2025) · Pharmaceuticals · doi:10.3390/ph18121794
“Antioxidants like glutathione, vitamin C, and vitamin E scavenge ROS directly, whereas superoxide dismutase (SOD), catalase, and glutathione peroxidase are enzymatic antioxidants [10].”
Wang, Y., Chen, Z., Peng, W., Hu, C., Wu, H., Lyu, R., Tan, B., Xu, T., & Ji, F. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1662049 · Cited by 1
“As a master regulatory pathway of antioxidant responses, Nrf2 can activate downstream genes (e.g., HO-1 ) by binding to antioxidant response elements, thereby enhancing cellular antioxidant capacity (41–43).”
Antioxidant and migration-modulating effects of lactoferrin in human keratinocytes
Azevedo, M. L., Pedra, N. S., Spanevello, R. M., & Lund, R. G. (2025) · Biochemistry and Cell Biology · doi:10.1139/bcb-2025-0327 · Cited by 1
Lipoxin A4 improves myocardial ischemia/reperfusion injury through the Notch1-Nrf2 signaling pathway
Yan, X., Chen, A., Gong, Y., Xu, J., Lu, J., Wang, L. W., Fan, Y., Gao, N., Zhou, L., Cao, H., et al. (2025) · Open Life Sciences · doi:10.1515/biol-2025-1200
Choi, E. Y., Uh, K., Lee, S.-B., Jeong, P., Kang, H., Jeon, S., Yun, J. H., Son, H.-C., Lim, K. S., An, Y. J., et al. (2025) · Antioxidants · doi:10.3390/antiox14121493 · Cited by 1
“…the nucleus, Nrf2 binds to antioxidant response elements (AREs) located in the promoter regions of target genes, inducing the transcription of key antioxidant-related genes such as glutathione peroxidase ( GPX ), superoxide dismutase ( SOD ), catalase ( CAT ), and heme oxygenase-1 ( HO-1 ) [26].”
Chronic Gallic Acid Treatment Attenuates Hippocampal Neurodegeneration in Aged Rats
González‐Cano, S. I., Juárez-Serrano, D., Handal‐Silva, A., Morán-Perales, J. L., Vázquez‐Roque, R. A., Galindo-Ramírez, F., Treviño, S., Guevara, J., & Díaz, A. (2025) · Synapse · doi:10.1002/syn.70036
“This action promotes the nuclear translocation of Nrf2 and its association with antioxidant response elements (ARE), thereby enhancing the increase in the concentration of certain antioxidant enzymes, including CAT, SOD, glutathione (GSH), and heme oxygenase-1 (HO-1) (Ngo and Duennwald 2022; Xie et al. 2019).”
Elias, K. M., Muliawan, W. F., Moon, M. J., & Kwakye, G. F. (2025) · NeuroToxicology · doi:10.1016/j.neuro.2025.103366
Cardenas-Garza, A., Kamberov, L., Dhaibar, H. A., Dudenbostel, T., Kolluru, G. K., Kevil, C. G., Oakley, R. H., Cidlowski, J. A., Cucullo, L., & Cruz‐Topete, D. (2025) · Cells · doi:10.3390/cells14242017
“GPX2 is a selenium-dependent enzyme that reduces lipid peroxides [29], while SOD3 diminishes free radical accumulation [29], with both enzymes playing key roles in cardioprotection [30].”
Thompson, J. C., Park, A., Kouakou, Y. I., Miller, Z. A., Darwich, N. F., Adappa, N. D., Palmer, J. N., Carey, R. M., & Lee, R. J. (2025) · International Forum of Allergy & Rhinology · doi:10.1002/alr.70084 · Cited by 1
“We hypothesize this may be due to previously reported downregulation of antioxidant transcription factor Nrf-2 in CF [ 61–63 ], which may decrease cellular responses to oxidative stressors [ 64 ].”
da Costa, P. E., & Baptista, M. S. (2025) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2025.113349
Tesvichian, S., Rodpan, A., Sangtanoo, P., Saisavoey, T., Buakeaw, A., Kanwal, S., Liangsakul, J., Sopon, A., Karnchanatat, A., & Srimongkol, P. (2025) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2025.102619
Lung cancer targeting by trimethoxy flavans: a molecular simulation study
Tasnim, S. A., Suha, H. N., Nawar, S. E., Almatarneh, M. H., Al-Msiedeen, A. M. H., Abdallah, S., Hossain, I., Bari, M. A. U., Poirier, R. A., & Uddin, K. M. (2025) · Physical Chemistry Chemical Physics · doi:10.1039/d5cp03925h
Neuroprotective Potential of Melatonin via ERK1/2 Dependent Nrf2 Activation
Medawaththa, N. S., Raveesha, S., Gonawala, L., & Wijekoon, N. (2026) · Springer eBooks · doi:10.1007/978-981-95-4751-7_7
Wahjuni, S., Bawa, I. G. A. G., Laksmiwati, A. A. I. A. M., Asih, I. A. R. A., & Sawitri, N. M. N. (2025) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3302
NRF1 and NRF2 Expression in Preeclamptic Placentas: A Comparative Observational Study
Kaplan, Ş., Karabat, M. U., Sancar, M., Aşir, F., & Ağaçayak, E. (2026) · Life · doi:10.3390/life16010089
“Downregulated NRF1-associated pathways were enriched in glutathione metabolism, HIF-1, and AMPK signaling, all essential for maintaining mitochondrial and metabolic balance [9,12,29].”
Cold gas plasma-oxidized insulin modulates THP-1 monocyte signaling independent of NF-kB
Clemen, R., Dethloff, W., Arlt, K., Weltmann, K. D., von Woedtke, T., & Bekeschus, S. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118962
Sesame-based interventions for stroke and stroke-related disorders: A systematic review
Suleiman, N., Uhuami, A. O., Ibrahim, B., Sanusi, F., Abdulazeez, N., Onimisi, O. B., & Bilbis, L. S. (2026) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2026.100495
Haritha, C. V., Kumawat, S., Madabhavi, P. M., Sharma, M., Sharma, A., Aneesha, V. A., Karikalan, M., Jadhav, S. E., Parida, S., Singh, T. U., et al. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178533
Animal Models of Acute Exacerbations COPD: Mechanistic Insights and Translational Challenges
Dewi, R. S., Wuyung, P. E., Louisa, M., Sandhiutami, N. M. D., & Pratomo, I. P. (2026) · Sciences of Pharmacy · doi:10.58920/sciphar0501482
Widowati, W., Tjokropranoto, R., Onggowidjaja, P., Na, M. K., Triharsiwi, D. N., Hadiprasetyo, D. S., Alexandro, G., Azis, R., Askar, K. A., & Utomo, H. S. (2026) · Natural Resources for Human Health · doi:10.53365/nrfhh/213305
“These results suggest that SDSPE can enhance cellular resistance against peroxides, potentially through catalase-like activity or stimulation of endogenous antioxidant enzymes, mechanisms that are often mediated via Nrf2 pathway activation (Ngo & Duennwald, 2022).”
da SILVA, F., Cappellaro, G. L., Zazula, M. F., Dahleh, M. M. M., Prigol, M., Guerra, G. P., Fernandes, L. C., Bertolini, G. R. F., Torrejais, M. M., Naliwaiko, K., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8523680/v1
Akla, N., Boudah, A., Bertomeu, T., Chatr‐aryamontri, A., Desjarlais, M., & Annabi, B. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104047 · Cited by 1
Greer, C., Liu, K., Cook, P., Pathak, S., Nadar, R. M., Dhanasekaran, M., Ann, N., Palekkodan, J., Al-Goshae, H. A. A., & Baskarpandian, V. V. (2026) · Nutritional neurosciences · doi:10.1007/978-981-95-5791-2_11
Rushendran, R., Narayanan, P. L., Kumar, M. J., Manoj, M. M. J., Gayathiri, K., & Vellapandian, C. (2026) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2026.100531
Mitra, N., Vickers, M. H., Lithander, F. E., Artuyants, A., Blenkiron, C., Foster, M., Phua, H. H., Pook, C. J., Wang, Z., Mithen, R. F., et al. (2026) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70397
“The Nrf2 pathway is known to regulate the expression of > 250 genes, with most genes involved in cryoprotective antioxidant responses and metabolic phase 2 detoxification processes [ 55, 56 ].”
OxStressNet: A Neural Network-Based Method for Quantitative Estimation of Oxidative Stress Levels
Xiao, J., Qu, Y., Xu, L., Wang, Z., Mu, X., & Xu, Y. (2025) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm66473.2025.11356665
“Additionally, we included HMOX1, NQO1, and NFE2L2 in the M-R gene set as they are critical components of the NRF2 pathway, which regulates antioxidant responses [18].”
Qi, S., Chang, J., Li, G., Zeng, X., & Liu, F. (2026) · Open Life Sciences · doi:10.1515/biol-2025-1241
Investigating Potential 5′ UTR G-Quadruplexes Within NRF2 mRNA
Esenkaya, H., & Bryant, J. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48020171 · Cited by 1
“As a transcription factor, NRF2 activates the expression of various genes involved in protecting cells from damage caused by reactive oxygen species (ROS) [31], heavy metals [32], and other environmental stressors [33].”
Suyal, M., Khan, A. M. A., Nabi, N., Sultana, F., Gupta, P., Ansari, M. A., Gautam, R., Kapur, P., Kohli, S., & Chandra, K. (2026) · The Journal of Medical Sciences · doi:10.5005/jp-journals-10045-00436
Kumari, P., & Singh, L. (2026) · NeuroMolecular Medicine · doi:10.1007/s12017-026-08908-x · Cited by 1
“The increased expression of antioxidant enzymes alleviates redox imbalance and maintains redox homeostasis (Ngo & Duennwald, 2022; Suzuki et al., 2023).”
Andrie, K. M., Musci, R. V., Walsh, M., Bork, S. B., Valenti, Z. J., Sanford, J. L., Campbell, M. A., Afzali, L., Afzali, M. F., Hamilton, K. H., et al. (2026) · Antioxidants · doi:10.3390/antiox15020212
“…factor that, when activated by stress (oxidative, inflammatory, or energetic), binds the antioxidant response element (ARE) and serves as a master regulator of hundreds of cytoprotective genes, including anti-inflammatory agents, phase I xenobiotics, and phase II antioxidant enzymes [6–9].”
Wang, C., Lin, K., Zhang, H. Z., Liu, T., Zeng, Z., Luo, W., Jiang, Y., Zhang, X., & Du, S. (2026) · Nutrition & Metabolism · doi:10.1186/s12986-026-01088-2
“Furthermore, oxidative stress and impaired antioxidant defense have been implicated in the pathogenesis of virtually all major human diseases, ranging from neuropsychiatric disorders to cardiovascular disease, diabetes, and cancer [36].”
Epigenetic Regulation of Oxygenases Involved in ROS Production in Metabolic Disorders
Sachan, N., Varshney, P. K., Chandra, P., & Singh, P. N. D. (2026) · Springer eBooks · doi:10.1007/978-3-032-11752-6_5
High palmitate induces ferroptosis in RIN-m5f cells via miR-3584-5p-mediated suppression of AQP7
Luan, C., Wang, Z., Li, M., Gao, F., Feng, R., Wang, Y., Wu, J., Yang, S., & Yang, M. (2026) · Scientific Reports · doi:10.1038/s41598-026-38935-4
Jung, C. R., Bang, E., Kim, G., Cheong, J., & Choi, Y. H. (2026) · Genes & Genomics · doi:10.1007/s13258-026-01744-0
Aderinto, N., Babawale, E. A., Olatunji, G. D., Kokori, E., Babarinde, F. O., Donaldy, W., Oyesiji, O. W., Vande-Pallen, F. V., Andibanbang, F., Obaje, A. A., et al. (2026) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-026-01094-4 · Cited by 1
“By increasing Nrf2 expression, mRNA therapy can bolster cellular resistance to oxidative stress, reducing damage from ROS that accumulate following ischemic injury [122].”
Nrf2 Modulators and the Prospects of Indigenous Medicinal Plants
Afolabi, A. A., Ezenabor, E. H., & Berena, G. A. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-5876-5.ch001 · Cited by 1
Microglial senescence and senolytic drugs
Ben-Azu, B., Sabbah, S., Awogbindin, I. O., Chidebe, E. O., Oritsemuelebi, B., Patel, D., Frenkel, D., & Tremblay, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27340-7.00010-3
Bae, M., Lee, M., Jeong, M., Lee, Y. S., Joo, H., Lee, Y., Lee, J., Kim, S., Ko, S., & Eun, Y. (2026) · Oncology Reports · doi:10.3892/or.2026.9088
“HO‑1, NQO1, SOD1 and SRXN1 are well‑known anti‑ oxidant enzymes involved in maintaining cellular redox homeostasis (36,37).”
Romero-Durán, M. A., Maldonado-Pichardo, M. C., Perez‐Aguilar, J. M., & Aguirre, V. M. B. (2026) · F1000Research · doi:10.12688/f1000research.177148.1 · Cited by 1
Animal Models of Acute Exacerbations COPD: Mechanistic Insights and Translational Challenges
Dewi, R. S., Wuyung, P. E., Louisa, M., Sandhiutami, N. M. D., & Pratomo, I. P. (2026) · Sciences of Pharmacy · doi:10.58920/sciphar0404482
Toukak, A. S., Gao, W., Wan, S., Li, N., & Chen, G. (2026) · Environmental Science Processes & Impacts · doi:10.1039/d5em00562k
Singh, N., Singh, V., & Singh, S. K. (2026) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2026.122159 · Cited by 1
Mitochondrial and brain health in type 2 diabetes
Kumar, R., Yashika, Prveen, Ranjan, S., Shahu, M., & Singh, S. B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-32848-0.00025-x
Nazari, A., Cheraghi, M., & Souri, F. (2025) · Epidemiology and Health System Journal · doi:10.34172/ehsj.26451
Gentiana lutea Root Extract Attenuates Radiation-Induced Damage in Human PBMCs in vitro
Kostic, M., Tričković, J. F., Radošević, K., Pašti, T. D. L., Stanković, S., Kolić, I., Stanković, A., & Šobot, A. V. (2026) · Dose-Response · doi:10.1177/15593258261435484
Chukwuma, I. F., Eze, O. I., Okeke, O. C., Apeh, V. O., Ezeorba, T. P. C., & Okafor, C. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.202502832
“This enables Nrf2 to migrate to the nucleus, leading to the activation of antioxidant response element (ARE)-dependent genes that shield against oxidative damage [ 14 ].”
Zhuang, Z., Guan, B., Wang, Y., Lin, X., Cai, H., Chen, B., Li, S., Liu, X., Zhuang, J., & Guan, G. (2026) · Cellular Oncology · doi:10.1007/s13402-026-01187-5
“Given that the transcription factor Nrf2 serves as a master regulator of the anti - oxidant response, controlling a network of genes involved in glutathione metabolism and ROS clearance [30], we hypothesized that NUAK1 mediates its transcriptional control of GPX4 through Nrf2.”
Metadata
- Authors
- Ngo, V., & Duennwald, M. L.
- Affiliations
- Western University (CA)
- Corresponding author
- Duennwald, Martin L.
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2022-11-27
- Volume
- 11
- Issue
- 12
- Pages
- 2345
- ISSN
- 2076-3921 (ISSN-L)
- PMC
- PMC9774434
- OpenAlex
- W4310211651
- Semantic Scholar
- ae6aa01efc202b0f3f701cefd15f11f215aa3aa5
- Cited by
- 1,130
- References
- 236
- Citations by year
- 2026: 415 · 2025: 448 · 2024: 200 · 2023: 67
- FWCI
- 18.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Antioxidants (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- TBCRU (n/a)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Keywords
- Nrf2, oxidative stress, reactive oxygen species, antioxidant defense, antioxidant enzymes, Nrf2 activation, neurodegenerative diseases, cardiovascular disease, diabetes mellitus, cancer, detoxification
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.